'Year post exclusivity adverse' presentation slideshows

Year post exclusivity adverse - PowerPoint PPT Presentation

One Year Post Exclusivity Adverse Event Review: Desloratadine Pediatric Advisory Committee Meeting September 15, 2004

One Year Post Exclusivity Adverse Event Review: Desloratadine Pediatric Advisory Committee Meeting September 15, 2004

One Year Post Exclusivity Adverse Event Review: Desloratadine Pediatric Advisory Committee Meeting September 15, 2004. Jane Filie, MD Medical Officer Division of Pediatric Drug Development Center for Drug Evaluation and Research Food and Drug Administration. Background Drug Information .

★ ★ ★ ★ ★

883 views • 16 slides
Solomon Iyasu, MD, MPH Medical Team Leader Division of Pediatric Drug Development Center for Drug Evaluation and Researc

Solomon Iyasu, MD, MPH Medical Team Leader Division of Pediatric Drug Development Center for Drug Evaluation and Researc

One Year Post Exclusivity Adverse Event Review as Mandated by the Best Pharmaceuticals for Children Act Pediatric Subcommittee of the Anti-infective Drugs Advisory Committee Meeting June 9, 2004. Solomon Iyasu, MD, MPH Medical Team Leader

★ ★ ★ ★ ★

300 views • 11 slides
One Year Post Exclusivity Adverse Event Review: Ofloxacin Ophthalmic Pediatric Advisory Committee Meeting September 15,

One Year Post Exclusivity Adverse Event Review: Ofloxacin Ophthalmic Pediatric Advisory Committee Meeting September 15,

One Year Post Exclusivity Adverse Event Review: Ofloxacin Ophthalmic Pediatric Advisory Committee Meeting September 15, 2004. Hari Cheryl Sachs, MD, FAAP Medical Officer Division of Pediatric Drug Development Center for Drug Evaluation and Research Food and Drug Administration.

★ ★ ★ ★ ★

300 views • 11 slides
One Year Post Exclusivity Adverse Event Review: Glimepiride Pediatric Advisory Committee Meeting November 16, 2006

One Year Post Exclusivity Adverse Event Review: Glimepiride Pediatric Advisory Committee Meeting November 16, 2006

One Year Post Exclusivity Adverse Event Review: Glimepiride Pediatric Advisory Committee Meeting November 16, 2006. Hari Cheryl Sachs, MD, FAAP Medical Officer Pediatric and Maternal Health Staff Office of New Drugs Center for Drug Evaluation and Research Food and Drug Administration.

★ ★ ★ ★ ★

396 views • 8 slides

View Year post exclusivity adverse PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Year post exclusivity adverse PowerPoint presentations. You can view or download Year post exclusivity adverse presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.